JESSICA GERNER: Open Payments
NPI 1740834241 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 39 payments from 21 companies in 2025. Trend: 2023 $398 · 2024 $561 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $101 |
| ABBVIE INC. | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| PFIZER INC. | 3 | $51 |
| Lilly USA, LLC | 2 | $49 |
| Amgen Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Abbott Laboratories | 1 | $30 |
Products named: REXULTI, MOUNJARO, OTEZLA, Cologuard Collection Kit, SHINGRIX, QULIPTA, AIRSUPRA, ETERNA.
Industry payments across IN — which companies pay providers there.
